Back
ESC Premium Access

Implantation of bioresorbable scaffolds in patients with indication for oral anticoagulation: is it safe?

Session: Poster session 6 - Adjunctive medical therapy in coronary artery disease
Topic: Adjunctive medical therapy
Speaker: Doctor N. Boeder (Giessen, DE)
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Doctor Niklas Frederik Boeder

Justus-Liebig University of Giessen, Giessen (Germany)
0 follower

26 more presentations in this session

Effects of statin therapy on plasma proprotein convertase subtilisin/kexin type 9 and sortilin levels in statin-naive patients with coronary artery disease

Speaker: Doctor T. Nozue (Yokohama, JP)

Access
Abstract
Like
Thumbnail

Is routine combination of renin-angiotensin system blocker and beta blocker beneficial in low-risk myocardial infarction patients?

Access
Like
Thumbnail

Renalguard to prevent acute kidney injury in high risk patients undergoing coronary interventions

Speaker: Doctor V. Gritti (Cinisello Balsamo, IT)

Access
Abstract
Slides
Like
Thumbnail

Benefit of early statin initiation within 48 hours after admission in patients with acute myocardial infarction

Speaker: Associate Professor M. Kim (Gwangju, KR)

Access
Abstract
Slides
Like
Thumbnail

Prescription of statins and one year risk of major clinical outcomes among ACS patients with extremely low LDL-c (<70mg/dl): data from CPACS studies

Speaker: Doctor Y. Sun (Beijing, CN)

Access
Abstract
Like
Thumbnail

Access the full session

Poster session 6 - Adjunctive medical therapy in coronary artery disease

Speakers: Doctor N. Boeder, Doctor T. Nozue, Doctor V. Gritti, Associate Professor M. Kim, Doctor Y. Sun
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources